https://www.selleckchem.com/pr....oducts/simufilam.htm
In patients suffering from malignancy, long-term ECMO support seems to be a factor of adverse prognosis, if not futile.Extracorporeal membrane oxygenation (ECMO) use in acute respiratory failure is increasing. We aim to compare characteristics and outcomes of patients with prolonged (≥21 days) veno-venous (VV) ECMO runs (pECMO), to patients with short ( less then 21 days) VV ECMO runs (sECMO). The observational retrospective single-center study compared patients who received VV ECMO from January 2018 to June 2019 at Prince Mohamed Bin